Recap: Larimar Therapeutics Q4 Earnings
Recap: Larimar Therapeutics Q4 Earnings
Revenue was down $0 from the same period last year.Larimar Therapeutics (NASDAQ:LRMR) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:05 PM.
Larimar Therapeutics（納斯達克股票代碼：LRMR）於2024年3月14日星期四下午4點05分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Larimar Therapeutics missed estimated earnings by -20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.
Larimar Therapeutics報告的每股收益爲-0.3美元，未達到預期的-20.0％，而預期的收益爲-0.25美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.01 which was followed by a 14.000000000000002% increase in the share price the next day.
上個季度，該公司的每股收益超過0.01美元，隨後第二天股價上漲了14.0000000000002％。
** Listen to the earnings announcement yourself by clicking here. **
** 點擊此處親自收聽業績公告。**
To track all earnings releases for Larimar Therapeutics visit their earnings calendar here.
要追蹤Larimar Therapeutics發佈的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
